The International Society for Cell and Gene Therapy (ISCT) published a watchdog report authored by IMPACT center…
Maximiliano KunzeFebruary 24, 2023
Cells for Cells ('C4C'), a clinical-stage biotech pioneering allogeneic stem cell and stem-cells-derived therapeutics for…
tactech userJuly 18, 2022
After two years of the COVID-19 pandemic, scientists from different parts of the world met…
tactech userJune 17, 2022
Recent Posts
- ISCT highlights observations from major Chilean advanced therapy developer group on Latin American regulation for Regenerative Medicine products in its recent Telegraft issue
- Chile’s Ministry of Science recognizes Cells for Cells as university spin-off success case in white paper
- Cells for Cells treats the first-ever patient with an exosome-produced therapy for osteoarthritis
- Cells for Cells presented groundbreaking results of three extracellular vesicles products at ISCT and ISEV annual meetings
- Cells for Cells featured in Startups Latam’s 2022 report
